HR 7693 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill gives makers of drugs for rare diseases extra time — 180 days — to be the only ones allowed to sell those drugs. This extension applies to drugs that had their applications submitted during the COVID-19 emergency period.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.